Development of diagnostic tools applicable to clinical practice
- To develop new-generation MFC and NGS. Applicability for diagnosis and therapeutic monitoring
- To develop diagnostic tools to be used in the clinical practice
- To study and implement biomarkers and therapeutic monitoring to investigate new prognostic factors or response predictors, by novel molecular methods.
- To develop techniques of using circulating tumor DNA as a liquid biopsy component in oncohematological diseases management as a non-invasive alternative to tissue biopsy.
Such Taboada, EsperanzaLeading Researcher
